脑膜瘤的致病变体和预后:系统性审查和元分析
Rubén David Dos Reis Zuniga1, Gabriel Sant'Ana Carrijo1, Matheus Rocha do Vale1
1Centro Universitário FMABC, São Paulo, Brazil.
World neurosurgery
|April 20, 2025
概括
像TERTp和NF2这样的遗传变异显著影响内脑膜瘤的预后. 识别这些标志物可以改善患者风险分层和个性化治疗策略,以获得更好的结果.
科学领域:
- 神经瘤学神经瘤学
- 遗传学 是一个遗传学.
- 瘤生物学 瘤生物学
背景情况:
- 内脑膜瘤是最常见的原发性脑瘤.
- 虽然通常是良性的,但某些遗传变化会导致攻击性行为,复发率增加和生存率降低.
研究的目的:
- 系统地审查和分析与内脑膜瘤预后相关的遗传变化.
- 确定关键的遗传标记,用于风险分层和个性化治疗.
主要方法:
- 系统性审查和对2024年11月之前发表的研究的元分析.
- 在PubMed,EMBASE,Web of Science和Scopus数据库中进行了搜索.
- 包括具有预后数据和至少五名患者的研究,由两名审查员独立提取数据.
主要成果:
- 20项研究符合3032项确定的纳入标准.
- 端粒酶逆转录酶促进剂 (TERTp) 和神经纤维素瘤2型 (NF2) 变体与较短的无复发存活 (RFS) 和整体存活 (OS) 相关.
- TERTp:HR 4.35用于RFS,HR 2.55用于OS. NF2:HR 1.49用于RFS,HR 2.98用于OS. 克鲁佩尔样因子4显示有保护作用,而CDKN2A/B则显示有风险因子.
结论:
- 致病变体,特别是TERTp和NF2,是内脑膜瘤的关键预后标志物.
- 基因分析可以完善风险分层,并指导个性化治疗策略.
- 整合遗传数据可能会改善患者的治疗结果和生活质量.
更多相关视频
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
1.1K
10:58Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma
Published on: February 22, 2015
12.9K
相关概念视频
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Mismatch Repair
4.7K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
4.7K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
